1.
Characteristics | n (%) | CR | PR | SD | PD | ORR (%) | P | DCR (%) | P |
PS: performance status; EGFR: epidermal growth factor receptor; CR: complete response; PR: partial response; SD: stable response; PD: progressive disease; ORR: objective response rate; DCR: disease control response. | |||||||||
Gender | 0.785 | 0.108 | |||||||
Male | 21 (37.5) | 0 | 9 | 5 | 7 | 42.9 | 66.7 | ||
Female | 35 (62.5) | 0 | 17 | 13 | 5 | 48.6 | 85.7 | ||
Age (yr) | 0.999 | 0.999 | |||||||
< 70 | 26 (46.4) | 0 | 12 | 8 | 6 | 46.2 | 76.9 | ||
≥70 | 30 (53.6) | 0 | 14 | 10 | 6 | 46.7 | 80.0 | ||
PS (ECOG) | 0.087 | < 0.001 | |||||||
0-2 | 46 (82.1) | 0 | 24 | 18 | 4 | 52.2 | 91.3 | ||
3-4 | 10 (17.9) | 0 | 2 | 0 | 8 | 20.0 | 20.0 | ||
Smoker | 0.038 | 0.017 | |||||||
Never | 36 (64.3) | 0 | 20 | 13 | 3 | 55.6 | 86.1 | ||
Light | 7 (12.5) | 0 | 4 | 1 | 2 | 57.1 | 71.4 | ||
Non-light | 13 (23.2) | 0 | 2 | 4 | 7 | 15.4 | 46.2 | ||
Stage | 0.592 | 0.522 | |||||||
Ⅲb | 3 (5.4) | 0 | 2 | 0 | 1 | 66.7 | 66.7 | ||
Ⅳ | 53 (94.6) | 0 | 24 | 18 | 11 | 45.3 | 79.2 | ||
EGFR mutation | 0.010 | 0.129 | |||||||
19 deletion | 10 (17.9) | 0 | 9 | 1 | 0 | 90.0 | 100.00 | ||
L858R | 8 (14.3) | 0 | 3 | 4 | 1 | 37.5 | 87.5 | ||
Wild type | 2 (3.6) | 0 | 0 | 1 | 1 | 0.00 | 50.0 | ||
Unknown | 36 (64.3) | 0 | 14 | 12 | 10 | 38.9 | 72.2 | ||
Rash | 0.043 | 0.012 | |||||||
No | 40 (71.4) | 0 | 15 | 13 | 12 | 37.5 | 70.0 | ||
Yes | 16 (28.6) | 0 | 11 | 5 | 0 | 68.8 | 100.00 | ||
Diarrhea | 0.358 | 0.666 | |||||||
No | 50 (89.3) | 0 | 25 | 13 | 12 | 50.0 | 76.0 | ||
Yes | 6 (10.7) | 0 | 1 | 5 | 0 | 16.7 | 100.00 |